The Use of Ginkgo biloba Extract in Cardiovascular Protection in Patients with Diabetes

Diabetes: Oxidative Stress and Dietary Antioxidants

Volumn , Issue , 2013, Pages 165-172

  Lim, Soo ^a,b   Park, Kyong Soo ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Apoptosis; Atherosclerosis; Cardiovascular diseases; Diabetes; EGb761; Ginkgo biloba extracts; Inflammation; Oxidative stress

Indexed keywords

EID: 84902235429     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-405885-9.00017-6     Document Type: Chapter

References (69)

1. Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010 January, 87(1):4-14.
2. Zhang P., Zhang X., Brown J., Vistisen D., Sicree R., Shaw J., et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010 March, 87(3):293-301.
3. Rodriguez A.E., Maree A.O., Mieres J., Berrocal D., Grinfeld L., Fernandez-Pereira C., et al. Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: three year follow-up of the ERACI III registry. Eur Heart J 2007 September, 28(17):2118-2125.
4. Aronson D., Bloomgarden Z., Rayfield E.J. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol 1996 March 1, 27(3):528-535.
5. Patel A., MacMahon S., Chalmers J., Neal B., Billot L., Woodward M., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008 June 12, 358(24):2560-2572.
6. Gerstein H.C., Miller M.E., Byington R.P., Goff D.C., Bigger J.T., Buse J.B., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008 June 12, 358(24):2545-2559.
7. Gennaro G., Menard C., Michaud S.E., Deblois D., Rivard A. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor. Circulation 2004 November 23, 110(21):3367-3371.
8. Ashley E.A., Ferrara R., King J.Y., Vailaya A., Kuchinsky A., He X., et al. Network analysis of human in-stent restenosis. Circulation 2006 December 12, 114(24):2644-2654.
9. Valli G., Giardina E.G. Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects. J Am Coll Cardiol 2002 April 3, 39(7):1083-1095.
10. Zimmermann M., Colciaghi F., Cattabeni F., Di L.M. Ginkgo biloba extract: from molecular mechanisms to the treatment of Alzheimer's disease. Cell Mol Biol 2002 September, 48(6):613-623.
11. Kressmann S., Muller W.E., Blume H.H. Pharmaceutical quality of different Ginkgo biloba brands. J Pharm Pharmacol 2002 May, 54(5):661-669.
12. DeFeudis F.V., Drieu K. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr Drug Targets 2000 July, 1(1):25-58.
13. Smith J.V., Luo Y. Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761. J Alzheimers Dis 2003 August, 5(4):287-300.
14. Gohil K., Packer L. Global gene expression analysis identifies cell and tissue specific actions of Ginkgo biloba extract, EGb 761. Cell Mol Biol 2002 September, 48(6):625-631.
15. Oken B.S., Storzbach D.M., Kaye J.A. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 1998 November, 55(11):1409-1415.
16. Zimmermann M., Colciaghi F., Cattabeni F., Di L.M. Ginkgo biloba extract: from molecular mechanisms to the treatment of Alzheimer's disease. Cell Mol Biol 2002 September, 48(6):613-623.
17. Smith J.V., Luo Y. Studies on molecular mechanisms of Ginkgo biloba extract. Appl Microbiol Biotechnol 2004 May, 64(4):465-472.
18. 2+, CaMK II and PKA in EGb 761-induced insulin secretion in INS-1 cells. J Ethnopharmacol 2007 March 1, 110(1):49-55.
19. Kudolo G.B. The effect of three-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic beta-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus. J Clin Pharmacol 2001 June, 41(6):600-611.
20. 2+, CaMK II and PKA in EGb 761-induced insulin secretion in INS-1 cells. J Ethnopharmacol 2007 March 1, 110(1):49-55.
21. Kudolo G.B. The effect of 3-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic beta-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus. J Clin Pharmacol 2001 June, 41(6):600-611.
22. Lim S., Yoon J.W., Kang S.M., Choi S.H., Cho B.J., Kim M., et al. EGb761, a Ginkgo biloba extract, is effective against atherosclerosis in vitro, and in a rat model of type 2 diabetes. PLoS One 2011, 6(6):e20301.
23. Zhang Y., Liu D. Flavonol kaempferol improves chronic hyperglycemia-impaired pancreatic beta-cell viability and insulin secretory function. Eur J Pharmacol 2011 November 16, 670(1):325-332.
24. Zhang Y., Zhen W., Maechler P., Liu D. Small molecule kaempferol modulates PDX-1 protein expression and subsequently promotes pancreatic beta-cell survival and function via CREB. J Nutr Biochem 2012 July 20.
25. Tiedge M., Lortz S., Drinkgern J., Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 1997 November, 46(11):1733-1742.
26. Smith J.V., Luo Y. Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761. J Alzheimers Dis 2003 August, 5(4):287-300.
27. Gohil K., Packer L. Global gene expression analysis identifies cell and tissue specific actions of Ginkgo biloba extract, EGb 761. Cell Mol Biol (Noisy -le-grand) 2002 September, 48(6):625-631.
28. DeFeudis F.V., Drieu K. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr Drug Targets 2000 July, 1(1):25-58.
29. Smith P.F., Maclennan K., Darlington C.L. The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF). J Ethnopharmacol 1996 March, 50(3):131-139.
30. Haines D.D., Varga B., Bak I., Juhasz B., Mahmoud F.F., Kalantari H., et al. Summative interaction between astaxanthin, Ginkgo biloba extract (EGb761) and vitamin C in suppression of respiratory inflammation: a comparison with ibuprofen. Phytother Res 2011, 25(1):128-136.
31. Smith J.V., Burdick A.J., Golik P., Khan I., Wallace D., Luo Y. Anti-apoptotic properties of Ginkgo biloba extract EGb 761 in differentiated PC12 cells. Cell Mol Biol (Noisy -le-grand) 2002 September, 48(6):699-707.
32. Eckert A., Keil U., Kressmann S., Schindowski K., Leutner S., Leutz S., et al. Effects of EGb 761 Ginkgo biloba extract on mitochondrial function and oxidative stress. Pharmacopsychiatry 2003 June, 36(Suppl. 1):S15-S23.
33. Libby P., Theroux P. Pathophysiology of coronary artery disease. Circulation 2005 June 28, 111(25):3481-3488.
34. Patterson C., Ruef J., Madamanchi N.R., Barry-Lane P., Hu Z., Horaist C., et al. Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo. J Biol Chem 1999 July 9, 274(28):19814-19822.
35. Madamanchi N.R., Moon S.K., Hakim Z.S., Clark S., Mehrizi A., Patterson C., et al. Differential activation of mitogenic signaling pathways in aortic smooth muscle cells deficient in superoxide dismutase isoforms. Arterioscler Thromb Vasc Biol 2005 May, 25(5):950-956.
36. Rodriguez M., Ringstad L., Schafer P., Just S., Hofer H.W., Malmsten M., et al. Reduction of atherosclerotic nanoplaque formation and size by Ginkgo biloba (EGb 761) in cardiovascular high-risk patients. Atherosclerosis 2007 June, 192(2):438-444.
37. Sastre J., Millan A., Garcia de la A.J., Pla R., Juan G., Pallardo, et al. A Ginkgo biloba extract (EGb 761) prevents mitochondrial aging by protecting against oxidative stress. Free Radic Biol Med 1998 January 15, 24(2):298-304.
38. Eckert A., Keil U., Kressmann S., Schindowski K., Leutner S., Leutz S., et al. Effects of EGb 761 Ginkgo biloba extract on mitochondrial function and oxidative stress. Pharmacopsychiatry 2003 June, 36(Suppl. 1):S15-S23.
39. Pietri S., Seguin J.R. d'Arbigny P, Drieu K, Culcasi M. Ginkgo biloba extract (EGb 761) pretreatment limits free radical-induced oxidative stress in patients undergoing coronary bypass surgery. Cardiovasc Drugs Ther 1997 April, 11(2):121-131.
40. Pietri S., Maurelli E., Drieu K., Culcasi M. Cardioprotective and antioxidant effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761). J Mol Cell Cardiol 1997 February, 29(2):733-742.
41. Auguet M., DeFeudis F.V., Clostre F. Effects of Ginkgo biloba on arterial smooth muscle responses to vasoactive stimuli. Gen Pharmacol 1982, 13(2):169-171.
42. Mahady G.B. Ginkgo biloba for the prevention and treatment of cardiovascular disease: a review of the literature. J Cardiovasc Nurs 2002 July, 16(4):21-32.
43. Liu F., Zhang J., Yu S., Wang R., Wang B., Lai L., et al. Inhibitory effect of Ginkgo biloba extract on hyperhomocysteinemia-induced intimal thickening in rabbit abdominal aorta after balloon injury. Phytother Res 2008 April, 22(4):506-510.
44. Ren D.C., Du G.H., Zhang J.T. Protective effect of Ginkgo biloba extract on endothelial cell against damage induced by oxidative stress. J Cardiovasc Pharmacol 2002 December, 40(6):809-814.
45. Gautam J., Kushwaha P., Swarnkar G., Khedgikar V., Nagar G.K., Singh D., et al. EGb 761 promotes osteoblastogenesis, lowers bone marrow adipogenesis and atherosclerotic plaque formation. Phytomedicine 2012 September 15, 19(12):1134-1142.
46. Clark W.M., Rinker L.G., Lessov N.S., Lowery S.L., Cipolla M.J. Efficacy of antioxidant therapies in transient focal ischemia in mice. Stroke 2001 April, 32(4):1000-1004.
47. Ahlemeyer B., Krieglstein J. Neuroprotective effects of Ginkgo biloba extract. Cell Mol Life Sci 2003 September, 60(9):1779-1792.
48. Chandrasekaran K., Mehrabian Z., Spinnewyn B., Chinopoulos C., Drieu K., Fiskum G. Neuroprotective effects of bilobalide, a component of Ginkgo biloba extract (EGb 761) in global brain ischemia and in excitotoxicity-induced neuronal death. Pharmacopsychiatry 2003 June, 36(Suppl. 1):S89-S94.
49. Clark W.M., Rinker L.G., Lessov N.S., Lowery S.L., Cipolla M.J. Efficacy of antioxidant therapies in transient focal ischemia in mice. Stroke 2001 April, 32(4):1000-1004.
50. Chandrasekaran K., Mehrabian Z., Spinnewyn B., Chinopoulos C., Drieu K., Fiskum G. Neuroprotective effects of bilobalide, a component of Ginkgo biloba extract (EGb 761) in global brain ischemia and in excitotoxicity-induced neuronal death. Pharmacopsychiatry 2003 June, 36(Suppl. 1):S89-S94.
51. van D.M., van R.E., Kessels A., Sielhorst H., Knipschild P. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial. J Clin Epidemiol 2003 April, 56(4):367-376.
52. Zhuang H., Pin S., Christen Y., Dore S. Induction of heme oxygenase 1 by Ginkgo biloba in neuronal cultures and potential implications in ischemia. Cell Mol Biol (Noisy -le-grand) 2002 September, 48(6):647-653.
53. Erbil G., Ozbal S., Sonmez U., Pekcetin C., Tugyan K., Bagriyanik A., et al. Neuroprotective effects of selenium and Ginkgo biloba extract (EGb761) against ischemia and reperfusion injury in rat brain. Neurosciences (Riyadh ) 2008 July, 13(3):233-238.
54. Lo E.H., Dalkara T., Moskowitz M.A. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 2003 May, 4(5):399-415.
55. Zhang Z., Peng D., Zhu H., Wang X. Experimental evidence of Ginkgo biloba extract EGB as a neuroprotective agent in ischemia stroke rats. Brain Res Bull 2012 February 10, 87(2-3):193-198.
56. Saleem S., Zhuang H., Biswal S., Christen Y., Dore S. Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury. Stroke 2008 December, 39(12):3389-3396.
57. Thanoon I.A., bdul-Jabbar H.A. Taha DA. Oxidative stress and c-reactive protein in patients with cerebrovascular accident (ischaemic stroke): The role of Ginkgo biloba extract. Sultan Qaboos Univ Med J 2012 May, 12(2):197-205.
58. Chen C., Wei T., Gao Z., Zhao B., Hou J., Xu H., et al. Different effects of the constituents of EGb761 on apoptosis in rat cerebellar granule cells induced by hydroxyl radicals. Biochem Mol Biol Int 1999 March, 47(3):397-405.
59. Pittler M.H., Ernst E. Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials. Am J Med 2000 March, 108(4):276-281.
60. Ryu K.H., Han H.Y., Lee S.Y., Jeon S.D., Im G.J., Lee B.Y., et al. Ginkgo biloba extract enhances anti-platelet and antithrombotic effects of cilostazol without prolongation of bleeding time. Thromb Res 2009 July, 124(3):328-334.
61. Ryu K.H., Han H.Y., Lee S.Y., Jeon S.D., Im G.J., Lee B.Y., et al. Ginkgo biloba extract enhances antiplatelet and antithrombotic effects of cilostazol without prolongation of bleeding time. Thromb Res 2009 July, 124(3):328-334.
62. Jung I.H., Lee Y.H., Yoo J.Y., Jeong S.J., Sonn S.K., Park J.G., et al. Ginkgo biloba extract (GbE) enhances the anti-atherogenic effect of cilostazol by inhibiting ROS generation. Exp Mol Med 2012 May 31, 44(5):311-318.
63. de Lima K.C., Schilichting C.L., Junior L.A., da Silva F.M., Benetoli A., Milani H. The Ginkgo biloba extract, EGb 761, fails to reduce brain infarct size in rats after transient, middle cerebral artery occlusion in conditions of unprevented, ischemia-induced fever. Phytother Res 2006 June, 20(6):438-443.
64. Kuller L.H., Ives D.G., Fitzpatrick A.L., Carlson M.C., Mercado C., Lopez O.L., et al. Does Ginkgo biloba reduce the risk of cardiovascular events?. Circ Cardiovasc Qual Outcomes 2010 January, 3(1):41-47.
65. Gardner C.D., Zehnder J.L., Rigby A.J., Nicholus J.R., Farquhar J.W. Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial. Blood Coagul Fibrinolysis 2007 December, 18(8):787-793.
66. Ryu K.H., Han H.Y., Lee S.Y., Jeon S.D., Im G.J., Lee B.Y., et al. Ginkgo biloba extract enhances antiplatelet and antithrombotic effects of cilostazol without prolongation of bleeding time. Thromb Res 2009 July, 124(3):328-334.
67. Le Bars P.L., Katz M.M., Berman N., Itil T.M., Freedman A.M., Schatzberg A.F. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA 1997 October 22, 278(16):1327-1332.
68. Pittler M.H., Ernst E. Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials. Am J Med 2000 March, 108(4):276-281.
69. Saleem S., Zhuang H., Biswal S., Christen Y., Dore S. Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury. Stroke 2008 December, 39(12):3389-3396.